Viva Biotech Cancels 11.01 Million Shares, Cutting Outstanding Stock by 0.52%

Bulletin Express07-14

Viva Biotech Holdings disclosed in a Next Day Disclosure Return dated 14 July 2026 that it has cancelled 11.01 million previously repurchased ordinary shares. The cancellation trims the company’s issued share capital by 0.52%, lowering the total number of outstanding shares from 2.10 billion to 2.09 billion.

The repurchased shares, acquired between 8 June and 26 June 2026, were cancelled on 14 July 2026 at a volume-weighted average price of HKD 1.137593 per share. Based on this price, the aggregate consideration for the cancelled shares is estimated at approximately HKD 12.53 million.

Following the cancellation, Viva Biotech now has 2.09 billion ordinary shares in issue and holds no treasury shares. The company confirmed that the repurchase and cancellation were duly authorised and carried out in compliance with all applicable Hong Kong Stock Exchange listing rules and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1193091226?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-14 17:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193091226","market":"hk","top_or_hot":-1,"title":"Viva Biotech Cancels 11.01 Million Shares, Cutting Outstanding Stock by 0.52%","media":"Bulletin Express","content":"<p>Viva Biotech Holdings disclosed in a Next Day Disclosure Return dated 14 July 2026 that it has cancelled 11.01 million previously repurchased ordinary shares. The cancellation trims the company’s issued share capital by 0.52%, lowering the total number of outstanding shares from 2.10 billion to 2.09 billion.</p>\n<p>The repurchased shares, acquired between 8 June and 26 June 2026, were cancelled on 14 July 2026 at a volume-weighted average price of HKD 1.137593 per share. Based on this price, the aggregate consideration for the cancelled shares is estimated at approximately HKD 12.53 million.</p>\n<p>Following the cancellation, Viva Biotech now has 2.09 billion ordinary shares in issue and holds no treasury shares. The company confirmed that the repurchase and cancellation were duly authorised and carried out in compliance with all applicable Hong Kong Stock Exchange listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viva Biotech Cancels 11.01 Million Shares, Cutting Outstanding Stock by 0.52%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViva Biotech Cancels 11.01 Million Shares, Cutting Outstanding Stock by 0.52%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-14 17:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Viva Biotech Holdings disclosed in a Next Day Disclosure Return dated 14 July 2026 that it has cancelled 11.01 million previously repurchased ordinary shares. The cancellation trims the company’s issued share capital by 0.52%, lowering the total number of outstanding shares from 2.10 billion to 2.09 billion.</p>\n<p>The repurchased shares, acquired between 8 June and 26 June 2026, were cancelled on 14 July 2026 at a volume-weighted average price of HKD 1.137593 per share. Based on this price, the aggregate consideration for the cancelled shares is estimated at approximately HKD 12.53 million.</p>\n<p>Following the cancellation, Viva Biotech now has 2.09 billion ordinary shares in issue and holds no treasury shares. The company confirmed that the repurchase and cancellation were duly authorised and carried out in compliance with all applicable Hong Kong Stock Exchange listing rules and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01873","symbol_name":"维亚生物","start_time":0,"source_url":"","article_id":"1193091226","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193091226","pubTimestamp":1784020909,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Viva Biotech Holdings disclosed in a Next Day Disclosure Return dated 14 July 2026 that it has cancelled 11.01 million previously repurchased ordinary shares. The cancellation trims the company’s...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01873":"维亚生物"},"translate_title":"Viva Biotech注销1101万股，流通股减少0.52%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01873":1},"content_text":"Viva Biotech Holdings disclosed in a Next Day Disclosure Return dated 14 July 2026 that it has cancelled 11.01 million previously repurchased ordinary shares. The cancellation trims the company’s issued share capital by 0.52%, lowering the total number of outstanding shares from 2.10 billion to 2.09 billion.\nThe repurchased shares, acquired between 8 June and 26 June 2026, were cancelled on 14 July 2026 at a volume-weighted average price of HKD 1.137593 per share. Based on this price, the aggregate consideration for the cancelled shares is estimated at approximately HKD 12.53 million.\nFollowing the cancellation, Viva Biotech now has 2.09 billion ordinary shares in issue and holds no treasury shares. The company confirmed that the repurchase and cancellation were duly authorised and carried out in compliance with all applicable Hong Kong Stock Exchange listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1193091226","isCrawlerRequest":true}